Mutual Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mutual Advisors's BIIB Position: Q3 2025 in Review
Mutual Advisors sold out of Biogen (BIIB) in Q3 2025, closing a stake of 1,780 shares — an estimated $234K sold.
Mutual Advisors first reported a position in BIIB in Q3 2018 and held it in 15 quarters. The position peaked at $1.19M in Q1 2023. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Mutual Advisors reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Mutual Advisors sold 1,780 Biogen shares in Q3 2025, an estimated $234K.
- Mutual Advisors first reported a position in Biogen in Q3 2018 and held it in 15 quarters.
- Mutual Advisors's Biogen position peaked at $1.19M in Q1 2023.
- 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Mutual Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.